How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation
Featuring Benjamin Lockshin, MD |
EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD
Related Media
Powered by Polaris TM